Eye study using donor corneas after keratoconus surgery
Part of Eyes & vision clinical trials.
This study looks at how donor corneas (for deep lamellar corneal transplant in keratoconus) are prepared using corneal collagen cross-linking, to see if it improves outcomes for people with keratoconus. You may be eligible if you meet vision and cornea shape/thickness requirements and can return for long follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (18 years or older)
- Your vision with glasses is worse than 0.3, or with rigid gas-permeable contacts is worse than 0.5 (or you cannot tolerate those contacts)
- Your cornea’s front-surface curvature is greater than 55 diopters
- Your thinnest corneal thickness is under 400 micrometers
- Be able and willing to return for follow-up visits for 36 months after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with keratoconus—a condition where the cornea (clear front part of the eye) thins and bulges into a cone shape—or early signs of it. Researchers will track corneal changes over time to better understand and detect the disease early.
This study tests a lab-grown (ex vivo) method of strengthening donor cornea tissue used in cornea transplants for people with keratoconus. It may help improve how well the transplanted cornea heals and functions.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.